Big Studies Test Effectiveness of Common Diabetes Meds
THURSDAY, Sept. 22, 2022 (HealthDay News) — Two common diabetes medications seem to outperform two others when it comes to controlling blood sugar levels, a large U.S. trial has found.The trial of more than 5,000 people with type 2 diabetes found tha…
Learn MoreA Honey of a Study: Well-Fed Bears Give Clues to Human Diabetes
THURSDAY, Sept. 22, 2022 (HealthDay News) — Every year, hibernating bears are able to feast, pack on a huge amount of weight and then lie around for months — all without suffering the health consequence of diabetes. Now researchers are closer to und…
Learn MoreNovel Bihormonal Artificial Pancreas Beneficial After Pancreatectomy
FRIDAY, Sept. 9, 2022 (HealthDay News) — Patients after total pancreatectomy receiving a novel, fully closed-loop bihormonal artificial pancreas (BIHAP) using both insulin and glucagon, experience significantly more time spent in euglycemia than thos…
Learn MoreAutomated Insulin Delivery Ups Time in Target Glucose Range in T1D
FRIDAY, Sept. 9, 2022 (HealthDay News) — Among patients with type 1 diabetes, percentage of time in the target glucose range is increased with the use of an open-source automated insulin delivery (AID) system, according to a study published in the Se…
Learn MorePreservation of C-Peptide Secretion Examined in Youth With T1D
THURSDAY, Sept. 8, 2022 (HealthDay News) — Intensive glucose control for 24 months does not slow the decline in residual C-peptide secretion among youth with new-onset type 1 diabetes, according to a study published in the Sept. 8 issue of the New En…
Learn MoreBetter Glucose Control in Youth With T1D Might Prevent Brain Changes
WEDNESDAY, Sept. 7, 2022 (HealthDay News) — A hybrid closed-loop insulin delivery system might prevent or reverse some alterations to the developing brain in adolescents with type 1 diabetes (T1D), according to a study published online Aug. 30 in Nat…
Learn MoreExperimental Insulin-in-a-Pill Shows Promise in Rat Study
MONDAY, Sept. 5, 2022 (HealthDay News) – People with type 1 diabetes who need to inject insulin a few times a day could eventually be switching to an easier-to-take tablet that dissolves inside the cheek. Canadian researchers working with rodents repo…
Learn MoreUn control estricto del azúcar en sangre mejora al cerebro de los adolescentes con diabetes tipo 1: estudio
MIÉRCOLES, 31 de agosto 2022 (HealthDay News) — Cuando los adolescentes con diabetes tipo 1 controlan mejor el azúcar en la sangre, sus cerebros se pueden beneficiar, muestra un nuevo ensayo clínico.Los investigadores encontraron que cuando los adole…
Learn MoreUn control estricto del azúcar en sangre mejora al cerebro de los adolescentes con diabetes tipo 1: estudio
MIÉRCOLES, 31 de agosto 2022 (HealthDay News) — Cuando los adolescentes con diabetes tipo 1 controlan mejor el azúcar en la sangre, sus cerebros se pueden beneficiar, muestra un nuevo ensayo clínico.Los investigadores encontraron que cuando los adole…
Learn MoreTight Blood Sugar Control Boosts Brain Power of Teens With Type 1 Diabetes: Study
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — When teenagers with type 1 diabetes get better control of their blood sugar, their brains may benefit, a new clinical trial shows.Researchers found that when teenagers started treatment with a newer technol…
Learn More